Evaluation of pharmacist consults within a collaborative enhanced primary care team model to improve diabetes care
PLOS ONE · 20.01.2023 · 18 (1) · e0280654
DOI: 10.1371/journal.pone.0280654 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.01.2023. Verfasst von Danielle Firkus und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, United States of America. Hauptthemen laut MEDLINE: Diabetes Mellitus, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pharmacists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
An enhanced primary care team model was implemented to provide proactive, longitudinal care to patients with diabetes, grounded in close partnership between primary care providers (PCPs), nurses, and Medication Management Services (MMS) pharmacists. The purpose of this study is to evaluate the impact of the MMS pharmacist involvement in the enhanced primary care model for patients with diabetes.
Methods
This retrospective cohort study compared the quality of diabetes care between patients referred to a pharmacist and propensity score matched controls who were not. Eligible patients were adults (age 18 to 75 years) enrolled in the enhanced primary care team process who did not meet at least one of four diabetes quality indicators at 13 Mayo Clinic Rochester primary care practice locations. The intervention examined was asynchronous e-consults by pharmacists affiliated with the primary care practice. Main measures The primary outcome was change in the proportion of patients meeting the composite of four diabetes treatment goals (D4), including hemoglobin A1c (HbA1c) control, blood pressure control, aspirin use, and statin use at six months from enrollment among patients who received pharmacist intervention compared to matched patients who did not. Secondary outcomes were each of the D4 goal individually.
Results
The proportion of patients meeting the D4 increased with pharmacist e-consults (N = 85) compared to matched controls with no review (N = 170) (27% vs 7.0%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, United States of America.
- Division of Community Internal Medicine, Geriatrics, and Palliative Care, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
- Division of Health Care Delivery Research, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota, United States of America.
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America.
ORCID-Profile: Danielle Firkus
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Firkus, D., McCoy, R. G., Matulis, J., Kessler, M., Mara, K., & Herges, J. (2023). Evaluation of pharmacist consults within a collaborative enhanced primary care team model to improve diabetes care. PLOS ONE, 18(1), e0280654. https://doi.org/10.1371/journal.pone.0280654
Vancouver
Firkus D, McCoy RG, Matulis J, Kessler M, Mara K, Herges J. Evaluation of pharmacist consults within a collaborative enhanced primary care team model to improve diabetes care. PLOS ONE. 2023;18(1):e0280654. doi:10.1371/journal.pone.0280654
BibTeX
@article{Firkus2023,
author = {Firkus, Danielle and McCoy, Rozalina G and Matulis, John and Kessler, Maya and Mara, Kristin and Herges, Joseph},
title = {Evaluation of pharmacist consults within a collaborative enhanced primary care team model to improve diabetes care},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {1},
pages = {e0280654},
doi = {10.1371/journal.pone.0280654}
}
EUVIMED